Treatment effects on sphingosine-1-phosphate and its receptors in major depressive disorder: implications for biomarkers
Xiao Yang, Le Wang, Anlong Jiang, Zeyue Mu, Jiamin Chen, Manxue Hu, Feng Zhang, Xueqian Xu, Ke Zhao, Fang Liu · 2026
Read Treatment effects on sphingosine-1-phosphate and its receptors in major depressive disorder: implications for biomarkers by Xiao Yang, Le Wang, Anlong Jiang, Zeyue Mu, Jiamin Chen, Manxue Hu, Feng Zhang, Xueqian Xu, Ke Zhao, Fang Liu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13418421.txt.
Description
Xiao Yang and co-authors measure a fat signalling molecule and its receptors in major depression, in a 2026 biomarker study. Diagnosis still rests on subjective judgement, so blood markers are sought. Fifty six patients were treated for eight weeks and compared with 42 healthy controls, with depression rated on two standard scales.
At baseline, the molecule S1P and receptors S1PR1 and S1PR3 all ran high in patients, strikingly so in women for the receptors. Levels fell toward normal with treatment. Starting S1P predicted how much symptoms improved, and the three marker panel separated patients from controls with high accuracy. Personalised psychiatry may benefit.
Catalog record
| CREATOR | Xiao Yang, Le Wang, Anlong Jiang, Zeyue Mu, Jiamin Chen, Manxue Hu, Feng Zhang, Xueqian Xu, Ke Zhao, Fang Liu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 40 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |